Narconon Ojai Celebrates Red Ribbon Week With Community Leaders and Substance Abuse Activists
04 nov. 2021 09h00 HE
|
Narconon Ojai
OJAI, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- In celebration of Red Ribbon Week, Narconon Ojai held its first annual golf tournament at the Ojai Valley Inn. The center joined together with...
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leader in Emerging Psychedelic-Assisted Psychotherapy Industry
04 nov. 2021 08h30 HE
|
Mydecine Innovations Group Inc.
NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) announces the availability of a broadcast titled, “Breaking the Habit:...
Achieve Life Sciences Announces Participation in November Investor Conferences
04 nov. 2021 08h30 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global...
Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisinicline’s Second Planned Indication for Nicotine E-cigarette Cessation
02 nov. 2021 08h30 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global...
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Part of Psychedelic Medicine Research Renaissance
02 nov. 2021 08h30 HE
|
Mydecine Innovations Group Inc.
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) today announces its placement in an editorial published by...
Achieve Life Sciences to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 9, 2021
26 oct. 2021 08h30 HE
|
Achieve Life Sciences
Seattle, WA/ Vancouver, BC , Oct. 26, 2021 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Clearmind Medicine Appoints Distinguished Addiction Experts Professor Wim van den Brink and Professor Gabriele Fischer to Its Scientific Advisory Board
14 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Ontario, Oct. 14, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
The Gary Sinise Foundation Avalon Network Announces Partnership with Forge Health and Warriors Heart to Expand Access to Substance Abuse Treatment for Veterans and First Responders
12 oct. 2021 08h54 HE
|
Gary Sinise Foundation
Los Angeles, Oct. 12, 2021 (GLOBE NEWSWIRE) -- In honor of World Mental Health Day this week, the Gary Sinise Foundation Avalon Network, Forge Health, and Warriors Heart announce a new partnership...
Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
07 oct. 2021 08h00 HE
|
Clearmind Medicine
Toronto, Ontario, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0), (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
Ryan Zofay is Proud to Announce the Opening of the California We Level Up Addiction Treatment / Dual-Diagnosis Center
06 oct. 2021 07h00 HE
|
We Level Up
LAKE ELSINORE, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Ryan Zofay is a successful entrepreneur and motivational speaker. He teaches personal development strategies that measurably improve...